Planet 13 Holdings (PLNH) Other Non-Current Liabilities (2020 - 2026)
Planet 13 Holdings (PLNH) posted quarterly Other Non-Current Liabilities of $1.3 million for Q1 2026, down 93.45% year-over-year from $19.3 million in Q1 2025, and down 96.17% quarter-over-quarter from $33.0 million in Q4 2025.
Planet 13 Holdings (PLNH) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has reported Other Non-Current Liabilities for 7 consecutive years, with $1.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Liabilities fell 93.45% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $1.3 million (down 93.45% YoY), while the FY2025 annual figure was $33.0 million, up 71.01% from the prior year.
- Other Non-Current Liabilities retreated to $1.3 million in Q1 2026 per PLNH's latest filing, from $33.0 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $33.0 million in Q4 2025 and bottomed at $28000.0 in Q1 2022.
- Historically, Other Non-Current Liabilities has averaged $7.2 million across 5 years, with a median of $33000.0 in 2024.
- Annual changes were most pronounced in 2022 — Other Non-Current Liabilities plunged 99.61% — and 2025, when it jumped 81421.93%.
- Planet 13 Holdings' Other Non-Current Liabilities stood at $28000.0 in 2022, then changed by 0.0% to $28000.0 in 2023, then jumped by 68905.27% to $19.3 million in 2024, then jumped by 71.01% to $33.0 million in 2025, then slumped by 96.17% to $1.3 million in 2026.
- Business Quant data shows PLNH's Other Non-Current Liabilities at $1.3 million in Q1 2026, $33.0 million in Q4 2025, and $1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Planet 13 Holdings | 52.64 Mn | 36.16 Mn | 12.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 40.11 Mn |
| Mar 31, 2026 | 1.27 Mn |
| Dec 31, 2025 | 33.04 Mn |
| Sep 30, 2025 | 1.26 Mn |
| Jun 30, 2025 | 26.90 Mn |
| Mar 31, 2025 | 19.32 Mn |
| Dec 31, 2024 | 19.32 Mn |
| Sep 30, 2024 | 33,000.00 |
| Jun 30, 2024 | 33,000.00 |
| Mar 31, 2024 | 33,000.00 |
| Jun 30, 2023 | 28,000.00 |
| Mar 31, 2023 | 28,000.00 |
| Sep 30, 2022 | 28,000.00 |
| Jun 30, 2022 | 28,000.00 |
| Mar 31, 2022 | 28,000.00 |
| Dec 31, 2021 | 28,000.00 |
| Mar 31, 2021 | 7.21 Mn |
| Dec 31, 2020 | 13.20 Mn |